Cat: PA2000-3302

Recombinant Human MFSD8 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    MFSD8

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    MFSD8;CLN7;Major facilitator superfamily domain-containing Protein 8

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    His tag N-Terminus

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q8NHS3

  • 表达区间

    1-40aa

  • 氨基酸序列

    MAGLRNESEQEPLLGDTPGSREWDILETEEHYKSRWRSIR

  • 分子量

    34.8 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

MFSD8 (Major Facilitator Superfamily Domain Containing 8) is a member of the major facilitator superfamily of transporters, which are integral membrane proteins playing crucial roles in the transportation of various substrates across cellular membranes. Recent research has highlighted the importance of MFSD8 in cellular function and its involvement in specific pathological conditions. Mutations in the MFSD8 gene have been linked to lysosomal storage disorders, particularly a rare condition known as Mahvash disease, characterized by progressive neurological deficits and other systemic symptoms. These findings underline the necessity for a deeper understanding of MFSD8's structure and function. Recombinant MFSD8 protein has become a focus of investigation, as it enables researchers to study the protein's transport mechanisms, substrate specificity, and interactions with other cellular components in vitro. By producing MFSD8 in a heterologous expression system, scientists aim to elucidate its role in cellular processes and develop potential therapeutic strategies. Additionally, the characterization of MFSD8's biochemical properties can lead to insights into the molecular pathogenesis of related disorders, ultimately contributing to the development of targeted treatments. The ongoing research into MFSD8 not only enhances our understanding of lysosomal biology but also opens new avenues for drug discovery and therapeutic interventions for diseases caused by transporter dysfunctions.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US